156 related articles for article (PubMed ID: 29100349)
1. Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma.
Gong M; Shi W; Qi J; Shao G; Shi Z; Wang J; Chen J; Chu R
Oncotarget; 2017 Sep; 8(44):76797-76806. PubMed ID: 29100349
[TBL] [Abstract][Full Text] [Related]
2. Detection of serum Alu element hypomethylation for the diagnosis and prognosis of glioma.
Chen J; Gong M; Lu S; Liu F; Xia L; Nie D; Zou F; Shi J; Ju S; Zhao L; Zuo H; Qi J; Shi W
J Mol Neurosci; 2013 Jun; 50(2):368-75. PubMed ID: 23657981
[TBL] [Abstract][Full Text] [Related]
3. [Association of etheno-DNA adduct and DNA methylation level among workers exposed to diesel engine exhaust].
Shen ML; He ZN; Zhang X; Duan HW; Niu Y; Bin P; Ye M; Meng T; Dai YF; Yu SF; Chen W; Zheng YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):556-561. PubMed ID: 28592103
[No Abstract] [Full Text] [Related]
4. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
5. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma.
Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W
Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997
[TBL] [Abstract][Full Text] [Related]
6. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.
Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS
Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
Guo Y; Long J; Lei S
J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527
[TBL] [Abstract][Full Text] [Related]
9. O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.
Balaña C; Ramirez JL; Taron M; Roussos Y; Ariza A; Ballester R; Sarries C; Mendez P; Sanchez JJ; Rosell R
Clin Cancer Res; 2003 Apr; 9(4):1461-8. PubMed ID: 12684420
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
11.
Wang Z; Jiang W; Wang Y; Guo Y; Cong Z; DU F; Song B
Biomed Rep; 2015 Jul; 3(4):543-548. PubMed ID: 26171163
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma.
Haque W; Teh C; Butler EB; Teh BS
J Neurooncol; 2022 Mar; 157(1):137-146. PubMed ID: 35103907
[TBL] [Abstract][Full Text] [Related]
13. Associations between DNA methylation in DNA damage response-related genes and cytokinesis-block micronucleus cytome index in diesel engine exhaust-exposed workers.
Zhang X; Li J; He Z; Duan H; Gao W; Wang H; Yu S; Chen W; Zheng Y
Arch Toxicol; 2016 Aug; 90(8):1997-2008. PubMed ID: 26410583
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
[TBL] [Abstract][Full Text] [Related]
15. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas.
Haque W; Thong E; Andrabi S; Verma V; Brian Butler E; Teh BS
J Clin Neurosci; 2021 Mar; 85():115-121. PubMed ID: 33581781
[TBL] [Abstract][Full Text] [Related]
17. Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide).
Pandith AA; Qasim I; Zahoor W; Shah P; Bhat AR; Sanadhya D; Shah ZA; Naikoo NA
Sci Rep; 2018 Apr; 8(1):6704. PubMed ID: 29712977
[TBL] [Abstract][Full Text] [Related]
18. Impact of MTHFR polymorphisms on methylation of MGMT in glioma patients from Northeast China with different folate levels.
Liu N; Jiang J; Song YJ; Zhao SG; Tong ZG; Song HS; Wu H; Zhu JY; Gu YH; Sun Y; Hua W; Qi JP
Genet Mol Res; 2013 Oct; 12(4):5160-71. PubMed ID: 24301776
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions.
Roszkowski K; Furtak J; Zurawski B; Szylberg T; Lewandowska MA
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834917
[TBL] [Abstract][Full Text] [Related]
20. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]